Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ
The company has entered into a three-year Deferred Prosecution Agreement
The company has entered into a three-year Deferred Prosecution Agreement
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
Oteseconazole Capsules were found to be safe and more effective than fluconazole
The company has new projects in development in Mumbai, Punjab, central and northern India, among others
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
IOL Chemicals and Pharmaceuticals has reported total income of Rs. 570.24 crores during the period ended June 30, 2023
Torrent Pharmaceuticals has reported total income of Rs. 2625 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated